Brimonidine and Timolol (Brimonidine Tartrate/Timolol Maleate)
Brimonidine and Timolol is indicated for lowering intraocular pressure in patients with glaucoma or ocular hypertension.
Questions a plan sponsor actually asks.
What is Brimonidine and Timolol used for?
Brimonidine and Timolol is indicated for lowering intraocular pressure in patients with glaucoma or ocular hypertension.
Is there a generic for Brimonidine and Timolol?
No. Brimonidine and Timolol is brand-only with no generic equivalents currently in market.
How much does my plan pay for Brimonidine and Timolol?
Across 329 Part D plans, Brimonidine and Timolol averages $2.16/unit (NADAC). Lowest available: $1.97/unit. Highest in distribution: $2.72/unit.
Is Brimonidine and Timolol on the FDA shortage list?
No. Brimonidine and Timolol is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.